tiprankstipranks
Bio-Path announces BP1002 trial advances to higher dose cohort
PremiumThe FlyBio-Path announces BP1002 trial advances to higher dose cohort
10d ago
Bio-Path files to sell common stock, warrants, no amount given
Premium
The Fly
Bio-Path files to sell common stock, warrants, no amount given
1M ago
Bio-Path Holdings Advances Clinical Pipeline for 2025
Premium
Company Announcements
Bio-Path Holdings Advances Clinical Pipeline for 2025
1M ago
Bio-Path Holdings Shifts Focus to Metabolic Program
PremiumCompany AnnouncementsBio-Path Holdings Shifts Focus to Metabolic Program
2M ago
Bio-Path outlines rationale for development of BP1001-A
Premium
The Fly
Bio-Path outlines rationale for development of BP1001-A
2M ago
Bio-Path Holdings Expands DNAbilize® Technology Applications
Premium
Company Announcements
Bio-Path Holdings Expands DNAbilize® Technology Applications
3M ago
Bio-Path Holdings Raises $4M Through Private Placement
PremiumCompany AnnouncementsBio-Path Holdings Raises $4M Through Private Placement
4M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
Bio-Path prices $4.0M at-the-market offering for $0.87 per share
Premium
The Fly
Bio-Path prices $4.0M at-the-market offering for $0.87 per share
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100